financetom
Business
financetom
/
Business
/
Evertec Insider Sold Shares Worth $623,114, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Evertec Insider Sold Shares Worth $623,114, According to a Recent SEC Filing
Sep 5, 2024 1:02 AM

05:13 PM EDT, 09/03/2024 (MT Newswires) -- Paola Perez-Surillo, Executive Vice President, on August 29, 2024, sold 18,253 shares in Evertec ( EVTC ) for $623,114. Following the Form 4 filing with the SEC, Perez-Surillo has control over a total of 36,558 shares of the company, with 36,558 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1559865/000156218024006601/xslF345X05/primarydocument.xml

Price: 33.13, Change: -0.49, Percent Change: -1.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Excelerate Energy Q2 beat adj profit estimates, raises full-year adj EBITDA guidance
Excelerate Energy Q2 beat adj profit estimates, raises full-year adj EBITDA guidance
Aug 11, 2025
Overview * Excelerate Q2 2025 revenue missed analyst expectations, per LSEG data * Liquefied natural gas infrastructure provider's adjusted net income and adj EBITDA beat analyst estimates, per LSEG data * Co raised full-year 2025 adjusted EBITDA guidance to $420-$440 mln Outlook * Excelerate raises full-year 2025 Adjusted EBITDA guidance to $420-$440 mln * Company expects 2025 maintenance capex between...
K92 Mining posts higher Q2 revenue, production rises by 43%
K92 Mining posts higher Q2 revenue, production rises by 43%
Aug 11, 2025
Overview * K92 Mining ( KNTNF ) Q2 revenue rises 102% yr/yr but misses analyst expectations * Net income for Q2 increases 539% yr/yr, reaching $39.2 mln * Co reports record cash position of $182.9 mln, progresses Stage 3 Expansion Outlook * K92 reaffirms 2025 production guidance of 160,000-185,000 oz AuEq * Company expects stronger production in second half of...
Amphastar Pharmaceuticals Gets FDA Approval for Generic Iron Sucrose Injection
Amphastar Pharmaceuticals Gets FDA Approval for Generic Iron Sucrose Injection
Aug 11, 2025
06:44 AM EDT, 08/11/2025 (MT Newswires) -- Amphastar Pharmaceuticals ( AMPH ) said Monday the US Food and Drug Administration has approved its abbreviated marketing application for iron sucrose injection in various doses under single-dose vials, previously known as AMP-002. The company said the injection is used to treat iron deficiency anemia in patients with chronic kidney disease. We look...
Copyright 2023-2026 - www.financetom.com All Rights Reserved